Literature DB >> 11082388

Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters.

K J Yoo1, R K Li, R D Weisel, D A Mickle, Z Q Jia, E J Kim, S Tomita, T M Yau.   

Abstract

BACKGROUND: Little is known about the effect of heart cell transplantation into the dilated cardiomyopathic myocardium. This study was designed to evaluate the effect of heart cell transplantation into dilated cardiomyopathic hamsters. METHODS AND
RESULTS: Ventricular heart cells were isolated from 4-week-old BIO 53. 58 hamsters and cultured for 2 weeks before transplantation. The cells were labeled with bromodeoxyuridine (BrdU) before transplantation for identification. Adult hamsters (17 weeks old) were used as recipients. Heart cells (4 x 10(6) cells) or culture medium was transplanted into the left ventricular free wall (transplantation and control groups, respectively, n=12 each). Sham-operated hamsters (n=12) underwent the surgery but not the transplantation. Cyclosporine A was administered subcutaneously to all hamsters daily after the operation. Four weeks after the transplantation, heart function was evaluated with the use of a Langendorff preparation. Histology showed severe focal myocardial necrosis in all groups. BrdU-stained tissue was found at the cell transplantation sites. The transplanted hearts had greater (P:<0. 001) developed pressures at all balloon volumes and improved dP/dt (transplantation 915+/-253 versus control 453+/-120 and sham 530+/-187 mm Hg/s, P:<0.001, balloon volume of 15 microL). No differences in ventricular function were found between control and sham-operated hamsters.
CONCLUSIONS: The transplanted ventricular heart cells formed cardiac-like tissue in cardiomyopathic myocardium and improved its contractile function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082388     DOI: 10.1161/01.cir.102.suppl_3.iii-204

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 2.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

3.  Stem cell treatment for complicated diabetes.

Authors:  Jong Yoon Bahk; Hoon Han; Youn Soo Lee
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

Review 4.  Cell transplantation in non-ischemic dilated cardiomyopathy. A novel biological approach for ventricular restoration.

Authors:  Nobuhisa Ohno; Paul W M Fedak; Richard D Weisel; Masashi Komeda; Donald A G Mickle; Ren-Ke Li
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-11

5.  Response by Luo et al to Letter Regarding Article, "Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice".

Authors:  Lan Luo; Tao-Sheng Li; Junnan Tang; Ke Cheng
Journal:  Circ Res       Date:  2017-05-26       Impact factor: 17.367

Review 6.  Diabetic heart dysfunction: is cell transplantation a potential therapy?

Authors:  Joel Price; Subodh Verma; Ren-Ke Li
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 7.  Myoblast-based cell transplantation.

Authors:  Philippe Menasché
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 8.  Animal models of dilated cardiomyopathy for translational research.

Authors:  F A Recchia; V Lionetti
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

9.  Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy.

Authors:  Ming Zhang; Jin Wei; Hu Shan; Hao Wang; Yanhe Zhu; Jiahong Xue; Lin Lin; Rui Yan
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy.

Authors:  Jing Guo; Haifeng Zhang; Junjie Xiao; Jian Wu; Yong Ye; Zheng Li; Yunzeng Zou; Xinli Li
Journal:  Int J Mol Sci       Date:  2013-04-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.